Altamira Therapeutics to Present at Two Upcoming RNA Therapeutics Conferences in Q1 2023
New, trends and future of RNA-based therapeuticsCompany's OligoPhoreTM / SemaPhoreTM polyplexes provide for efficient delivery of siRNA payloads into extrahepatic target cellsCompany's latest research
Source: finanznachrichten.de